Page last updated: 2024-08-25

nedaplatin and Cancer of the Urinary Tract

nedaplatin has been researched along with Cancer of the Urinary Tract in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujita, T; Hirayama, T; Ikeda, M; Iwamura, M; Matsumoto, K; Mochizuki, K; Nishi, M; Okazaki, M; Tabata, K; Taoka, Y	1
Demura, T; Harabayashi, T; Ishikawa, R; Koyanagi, T; Mitsuhashi, K; Murakumo, M; Seki, H; Shinohara, N; Suzuki, S; Toyota, H	1
Demura, T; Harabayashi, T; Matsuyama, H; Mitsuhashi, K; Murakumo, M; Nagamori, S; Nagao, K; Naito, K; Nonomura, K; Seki, H; Shinohara, N; Suzuki, S	1
Akaza, H; Aso, Y; Kotake, T; Matsumura, Y; Miki, T; Nishio, Y; Togashi, M; Yoshida, O	1

Trials

2 trial(s) available for nedaplatin and Cancer of the Urinary Tract

Article	Year
Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Treatment Outcome; Urologic Neoplasms	2006
Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group. Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Female; Humans; Japan; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Prostatic Neoplasms; Remission Induction; Testicular Neoplasms; Urologic Neoplasms	1992

Article

Year

Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy.

Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Treatment Outcome; Urologic Neoplasms

2006

Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group.

Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:3

Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Female; Humans; Japan; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Prostatic Neoplasms; Remission Induction; Testicular Neoplasms; Urologic Neoplasms

1992

Other Studies

2 other study(ies) available for nedaplatin and Cancer of the Urinary Tract

Article	Year
Gemcitabine plus nedaplatin as salvage therapy is a favorable option for patients with progressive metastatic urothelial carcinoma after two lines of chemotherapy. Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Salvage Therapy; Survival Rate; Urologic Neoplasms	2015
[Paclitaxel, ifosfamide, nedaplatin (TIN) for patients with metastatic urothelial cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Survival Rate; Thrombocytopenia; Urologic Neoplasms	2004

Article

Year

Gemcitabine plus nedaplatin as salvage therapy is a favorable option for patients with progressive metastatic urothelial carcinoma after two lines of chemotherapy.

Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:6

Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Salvage Therapy; Survival Rate; Urologic Neoplasms

2015

[Paclitaxel, ifosfamide, nedaplatin (TIN) for patients with metastatic urothelial cancer].

Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:4

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Survival Rate; Thrombocytopenia; Urologic Neoplasms

2004